CHINA PHARMA HOLDINGS, INC. Total Liabilities and Equity
CHINA PHARMA HOLDINGS, INC. (CPHI) had Total Liabilities and Equity of $44.71 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-14
- 2026-06-30: Liabilities and Equity $44.71M.
- 2026-03-31: Liabilities and Equity $45.14M.
- 2025-12-31: Liabilities and Equity $31.00M.
- 2025-09-30: Liabilities and Equity $15.80M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2026-06-30 | $44.71M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $45.14M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $31.00M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $15.80M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $13.77M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $14.22M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $14.89M 10-K · filed 2026-04-01 | |
| 2024-09-30 | $13.47M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $14.26M 10-Q · filed 2024-08-14 | |
| 2023-12-31 | $16.47M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $15.35M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $15.70M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $17.36M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $17.78M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $16.20M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $17.92M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $21.04M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $22.65M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $18.18M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $19.94M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $19.85M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $21.12M 10-K · filed 2022-03-30 | |
| 2020-09-30 | $21.12M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $23.17M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $22.44M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $22.24M 10-K · filed 2021-03-26 | |
| 2019-09-30 | $39.90M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $43.03M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $45.24M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $45.38M 10-K · filed 2020-03-30 | |
| 2018-09-30 | $52.53M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $58.31M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $62.13M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $59.95M 10-K · filed 2019-03-28 | |
| 2017-09-30 | $74.99M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $77.12M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $78.14M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $78.52M 10-K · filed 2018-04-02 | |
| 2016-09-30 | $87.41M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $91.98M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $97.03M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $96.51M 10-K · filed 2017-03-31 | $97.22M 10-K · filed 2016-03-30 |
| 2015-09-30 | $108.92M 10-Q · filed 2015-12-28 | $112.68M 10-Q · filed 2015-11-16 |
| 2015-06-30 | $115.41M 10-Q · filed 2015-12-28 | $121.24M 10-Q · filed 2015-08-14 |
| 2015-03-31 | $118.04M 10-Q · filed 2015-12-28 | $125.16M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $121.08M 10-K · filed 2016-03-30 | $132.08M 10-K · filed 2015-03-30 |
| 2014-09-30 | $140.53M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $146.03M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $154.34M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $157.61M 10-K · filed 2015-12-28 | |
| 2013-09-30 | $162.49M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $158.93M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $159.26M 10-Q · filed 2013-05-14 | |
| 2012-12-31 | $163.24M 10-K · filed 2014-03-20 | |
| 2012-09-30 | $166.05M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $164.89M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $163.62M 10-Q · filed 2012-05-14 | |
| 2011-12-31 | $156.39M 10-K · filed 2013-03-14 | |
| 2011-09-30 | $150.94M 10-Q/A · filed 2012-03-06 | $149.12M 10-Q · filed 2011-11-10 |
| 2011-06-30 | $143.44M 10-Q/A · filed 2011-09-06 | |
| 2010-12-31 | $131.75M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |